User's Manual

Dexcom G5x System User Guide
40
Lowering your A1C, increasing your time in your target range while
decreasing time in low/high BG range is believed to reduce your risk of
diabetes-related complications (Ohkubo, Y., 1995).
In some cases, patients perceived an increase in their quality of life and peace
of mind when using real-time CGM (Juvenile Diabetes Research Foundation
Continuous Glucose Monitoring Study Group, 2010).
What’s Next?
You’ve read the Safety Statements, reviewed the risks and benefits; now let’s
take a look at Dexcom’s G5x!
References:
Battelino, T., Phillip, M., Bratina, N., Nimri, R., Oskarsson, P., & Bolinder, J.
(2011). Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1
Diabetes. Diabetes Care , 34(4), 795-800.
Garg, S., Zisser, H., Schwartz, S., Bailey, T., Kaplan, R., Ellis, S., &
Jovanovic, L. (2006). Improvement in Glycemic Excursions With a
Transcutaneous, Real-Time Continuous Glucose Sensor: A Randomized
Controlled Trial. Diabetes Care , 29(1), 44-50.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring
Study Group (2010). Quality-of-Life Measures in Children and Adults With
Type 1 Diabetes. Diabetes Care , 33(10), 2175-2177.
Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., &
Shichiri, M. (1995). Intensive Insulin Therapy Prevents the Progression of
Diabetic Microvascular Complications in Japanese Patients With Non-insulin-
dependent Diabetes Mellitus: A Randomized Prospective 6-year Study.
Diabetes Research and Clinical Practice , 28(2), 103-117.
Tamborlane, W. V., Beck, R. W., Bode, B. W., Buckingham, B., Chase, H. P.,
Clemons, R., ... & Xing, D. (2008). Continuous Glucose Monitoring and
Intensive Treatment of Type 1 Diabetes. The New England Journal of
Medicine, 359(14), 1464-1476.
PDF compression, OCR, web optimization using a watermarked evaluation copy of CVISION PDFCompressor